Bio-Techne (TECH) announced a co-marketing and co-promotion agreement with Waters Corporation aimed at expanding the reach of advanced biotherapeutic characterization and development processes. The companies plan to combine their complementary expertise on charge separation – Bio-Techne’s MauriceFlex System – and liquid chromatography mass spectrometry – BioAccord LC-MS System from Waters – to deliver solutions that optimize workflows, improve precision, and accelerate development timelines. Application scientists from both companies are working on the analysis of additional classes of biomolecules and plan to exhibit the joint results in a poster at upcoming scientific conferences. This work will guide application notes, webinars, and presentations at upcoming Bio-Techne User Group Meetings to co-market each company’s advanced biotherapeutic characterization and development process capabilities.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TECH:
- Bio-Techne signs distribution agreement with MedSanTek in Turkey
- Gemini Bioproducts acquires selected FBS product rights from Bio-Techne
- Bio-Techne announces partnership with Leader Life Sciences
- Bio-Techne, ALZpath announce strategic partnership
- Bio-Techne Grants CFO Restricted Stock Units
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
